Immunologic and clinical correlations in rheumatic fever and rheumatic heart disease

Pediatric Infectious Disease Journal

Volumn 16, Issue 4, 1997, Pages 400-407

  Veasy, L George ^a   Hill, Harry R ^a  

^a UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

Author keywords

group A streptococci pathogenesis; Rheumatic fever; rheumatic heart disease

Indexed keywords

CD4 ANTIGEN; CD8 ANTIGEN; HYALURONIC ACID; M PROTEIN; MYOSIN; N ACETYLGLUCOSAMINE; PEPTIDOGLYCAN; TROPOMYOSIN;

ANTIBODY PRODUCTION; ANTIGEN PRESENTATION; ANTIGEN PRESENTING CELL; ANTIGEN RECOGNITION; ARTICLE; CELLULAR IMMUNITY; CROSS REACTION; HUMAN; HUMORAL IMMUNITY; PHARYNGITIS; PRIORITY JOURNAL; RHEUMATIC FEVER; RHEUMATIC HEART DISEASE; STREPTOCOCCUS GROUP A; T LYMPHOCYTE;

EID: 0030978295     PISSN: 08913668     EISSN: None     Source Type: Journal    
DOI: 10.1097/00006454-199704000-00012     Document Type: Article

References (83)

1. Gibofsky A, Zabriskie JB. Rheumatic fever and poststreptococcal reactive arthritis. Curr Opin Rheum 1995;7:299-305.
2. Wald, ER. The resurgence of rheumatic fever. Heart Dis Stroke 1992;1:391-4.
3. Stollerman GH. In: Stollerman GH, ed. Rheumatic fever and streptococcal infection. New York: Grune & Stratton, 1975: 104.
4. Markowitz M, Gordis L. In: Markowitz M, Gordis L, eds. Rheumatic fever. Philadelphia: Saunders, 1972:45.
5. Cairns LM. The immunology of rheumatic fever. NZ Med J 1988;101:388-91.
6. Gibofsky A, Zabriskie JB. Rheumatic fever: new insights into an old disease. Bull Rheum Dis 1993;42:5-7.
7. Cheadle WB. Harvean lectures on the various manifestations of the rheumatic state as exemplified in childhood and early life. Lancet 1889;1:821-32.
8. Wilson MG, Schweitzer MD, Lubschez R. The familial epidemiology of rheumatic fever. J Pediatr 1943;44:468-82.
9. Taranta A, Torosdag S, Metrakos JD, Jegier W, Uchida I. Rheumatic fever in monozygotic and dizygotic twins [Abstract]. Circulation 1959;20:778.
10. Ayoub EM, Barrett DJ, Maclaren NK, Krischer JP. Association of class II human histocompatibility leukocyte antigens with rheumatic fever. J Clin Invest 1986;77:2019-26.
11. Anastasiou-Nana MI, Anderson JL, Carlquist JF, Nanas JN. HLA-DR typing and lymphocyte subset evaluation in rheumatic heart disease: a search for immune response factors. Am Heart J 1986;112:992-7.
12. Maharaj B, Hammond MG, Appadoo B, Leary WP, Pudifin DJ. HLA-A, B DR and DQ antigens in black patients with severe chronic rheumatic heart disease. Circulation 1987; 765:259-61.
13. Guilherme L, Weidenback, W, Kiss M II, Snitcowsky R, Kalil J. Association of human leukocyte class II antigens with rheumatic fever or rheumatic heart disease in a Brazilian population. Circulation 1991;83:1995-8.
14. Taneja V, Mehra NK, Reddy KS, et al. HLA/DR/D2 antigens and reactivity to B cell alloantigen D8/17 in Indian patients with rheumatic heart disease. Circulation 1989;80:335-40.
15. Khosroshahi HE, Kahramanyol O, Doganci L. HLA and rheumatic fever in Turkish children. Pediatr Cardiol 1992; 13:204-7.
16. Afanas'ev IUI, Kadyrova RT, Iasdovski W. HLA associated immunological mechanisms in rheumatic affection of the myocardium. Ter Arkh 1995;67:67-9.
17. Williams RC. Host factors in rheumatic fever and heart disease. Hosp Pract 1982;4:125-8.
18. Poynton PJ, Paine A. The etiology of rheumatic fever. Lancet 1900;2:861-9.
19. Coombs CF. In: Coombs CF. Rheumatic heart disease. Bristol: John Wright and Sons, 1924:3, 15.
20. Lancefield RC. Specific relationship of cell composition to biological activity of hemolytic streptococci. Harvey Lect 1941;36:251-60.
21. McCarty M, Lancefield RC. Variations in the group specific carbohydrate of group A streptococci: I. Immunological studies on the carbohydrate of various strains. J Exp Med 1955; 102:11-28.
22. Collis WRF. Discussion on some problems concerning the prevention and treatment of acute rheumatic infection. Proc R Soc Med 1932;25:1631-6.
23. Coburn AF, Pauli RH. Studies on the immune response of the rheumatic subject and its relationship to activity of the rheumatic process: IV. Characteristics of strains of hemolytic streptococcus, effective and noneffective in initiating rheumatic activity. J Clin Invest 1935;14:755-62.
24. Rammelkamp CH, Denny FW, Wannamaker LW. Studies on the epidemiology of rheumatic fever in the armed services. In: Thomas L, ed. Rheumatic fever. Minneapolis: University of Minnesota Press, 1952:72-89.
25. Gordis L. The vertical disappearance of rheumatic fever in the United States: lessons in the rise and fall of the disease. Circulation 1985;72:1155-62.
26. Markowitz M. The decline of rheumatic fever: role of medical intervention. J Pediatr 1985;106:545-50.
27. Lancefield RC. Current knowledge of the type specific M antigens of group A streptococci. J Immunol 1962;89:307-13.
28. Fischetti VA. Streptococcal M protein. Sci Am 1991;264:58-65.
29. Bisno AL. Group A Streptococcal infections and acute rheumatic fever. N Engl J Med 1991;325:783-93.
30. Bessen DE, Sotir CM, Readdy TL, Hollingshead SK. Genetic correlates of throat and skin isolates of group A streptococci. J Infect Dis 1996;173:896-900.
31. Martin DR. Streptococcal infections: rheumatogenic streptococci reconsidered. NZ Med J 1988;101:394-6.
32. Bessen DE, Sotir, CM, Readdy TL, Hollingshead SK. Genetic correlates of throat and skin isolates of group A streptococci. J Infect Dis 1996;173:896-900.
33. Martin DR, Voss LM, Walker SJ, Lennon D. Acute rheumatic fever in Auckland, New Zealand: spectrum of associated group A streptococci different from expected. Pediatr Infect Dis J 1994;13:264-9.
34. Majeed HA, Yousof AM, Rotta J, Havlickpva H, Bahar G, Bahbahani K. Group A Streptococcal strains in Kuwait: a nine year prospective study of prevalence and associations. Pediatr Infect Dis J 1992;11:295-300.
35. Relf WA, Martin DR, Sriprakash KS. Identification of sequence types among the M-nontypable group A streptococci. J Clin Microbiol 1992;30:3190-4.
36. Beachey EH. Binding of group A streptococci to human oral mucosal cells by lipoteichoic acid. Trans Assoc Am Physicians 1975;88:285-92.
37. Beachey EH, Ofek I. Epithelial cell binding of group A streptococci by lipoteichoic acid on fembrial denuded of M protein. J Exp Med 1976;143:759-70.
38. Bartlett MA, Duncan JL. Adherence of group A streptococci to human epithelial cells. Infect Immun 1978;20:200-8.
39. Selinger DS, Julie N, Reed WP, Williams RC Jr. Adherence of group A streptococci to pharyngeal cells: a role in the pathogenesis of rheumatic fever. Science 1978;201:455-7.
40. Courtney HS, Dale JB, Hasty DI. Differential effects of the streptococcal fibronectin-binding protein, FBP54, on adhesion of group A streptococci to human buccal cells and HEp-2 tissue culture cells. Infect Immun 1996;64:2415-9.
41. Patarroyo ME, Winchester A, Vejerano A, et al. Association of a B cell alloantigen with susceptibility to rheumatic fever. Nature 1979;278:173-4.
42. Gray ED, Regelmann WE, Abdin Z, et al. Compartmentalization of cells bearing "rheumatic" cell surface antigens in peripheral blood and tonsils in rheumatic heart disease. J Infect Dis 1987;155:247-52.
43. Andrushen IN. Data towards the anatomic substantiation of the spread of infection from the tonsils and pharynx to the heart. Arkh Anat 1969;56:45. Quoted in Wannamaker LW. The chain that links the throat to the heart. Circulation 1973;48:9-18.
44. Andrushen IN. Data towards the anatomic substantiation of the spread of infection from the tonsils and pharynx to the heart. Arkh Anat 1969;56:45. Quoted in Wannamaker LW. The chain that links the throat to the heart. Circulation 1973;48:9-18.
45. Kaplan MH, Meyeserian M. Immunologic cross reaction between group A streptococcal cells and human heart tissue. Lancet 1962;1:706-10.
46. Kaplan MH, Bolande R, Rakita L, Blair J. Presence of bound immunoglobulins and complement in the myocardium in acute rheumatic fever. N Engl J Med 1964;271:637-45.
47. Zabriskie JB, Freimer EH. An immunologic relationship between the group A streptococcus and mammalian muscle. J Exp Med 1966;124:661-8.
48. Husby G, van de Rijn I, Zabriskie JB, Abdin Z, Williams RC Jr. Antibodies reacting with cytoplasm of subthalamic and caudate nuclei neurons in chorea and acute rheumatic fever. J Exp Med 1976;144:1094-110.
49. Kaplan EL, Johnson DR, Cleary PP. Group A streptococcal serotypes isolated from patients and sibling contacts during the resurgence of rheumatic fever in the United States in the mid 1980s. J Infect Dis 1989;159:101-3.
50. Marcon MJ, Hribar MM, Hosier D. Occurrence of mucoid M-18 Streptococcus pyogenes in a central Ohio pediatric population. J Clin Microbiol 1988;26:1539-42.
51. Bronze MS, Dale JB. The reemergence of serious group A streptococcal infections and acute rheumatic fever. Am J Med Sci 1996;311:41-54.
52. Dudding BA, Ayoub EM. Persistence of group A antibody in patients with rheumatic valvular disease. J Exp Med 1968; 128:1081-98.
53. Appleton RS, Victorica, BE, Tamer D, Ayoub E. Specificity of persistence of antibody to the streptococcal group A carbohydrate in rheumatic valvular disease. J Lab Clin Med 1985; 105:114-9.
54. Salvadori LG, Blake MS, McCarty M, Tai JY, Zabriskie JB. Group A Streptococcus-liposome ELISA antibody titers to group A polysaccharide and opsinophagocytic capabilities of the antibodies. J Infect Dis 1995;171:593-600.
55. van de Rijn I. Structure and immunochemistry of the group A streptococcal membranes. In: Read SE, Zabriskie JB, eds. Streptococcal diseases and the immune response. New York: Academic Press, 1980:161-76.
56. Dale JB, Simpson W, Ofek I, Beachey EH. Blastogenic responses of human lymphocytes to structurally defined polypeptide fragments of streptococcal M protein. J Immunol 1981;126:1499-504.
57. Watanabe-Ohnishi R, Aelion J, LeGroz L, et al. Characterization of unique human TCR VB specificities for a family of streptococcal superantigens represented by rheumatogenic serotypes of M protein. J Immunol 1994;22:2066-72.
58. Abbott WG, Skinner MA, Voss L, et al. Repertoire of transcribed peripheral blood T-cell receptor beta chain variable-region genes in acute rheumatic fever. Infect Immun 1996; 64:2842-5.
59. Lydyard P, Grossi C. In: Roitt I, Brostoff J, Male D, eds. Immunology. London: Mosby, 1996:2.5.
60. Murphy GE. The histopathology of rheumatic fever: a critical review. In: Thomas L, ed. Rheumatic fever. Minneapolis: Minnesota Press, 1952:28-51.
61. MacCallum WG. Rheumatic lesions of the left auricle of the heart. Bull Johns Hopkins Hosp 1924;35:329-34.
62. Khanna AK, Buskirk, DR, Williams RC Jr, et al. Presence of a non-HLA B cell antigen in rheumatic fever patients and their families as defined by a monoclonal antibody. J Clin Invest 1989;83:1710-6.
63. Stollerman. GH. In: Stollerman GH. Rheumatic fever and streptococcal infection. New York: Grune & Stratton, 1975: 152.
64. Narula J, Chopra P, Talwar KK, et al. Does endomyocardial biopsy aid in the diagnosis of rheumatic carditis? Circulation 1993;88:2198-205.
65. Denny FW. T. Duckett Jones and rheumatic fever in T. Duckett Jones memorial lecture. Circulation 1986;1987;76: 963-70.
66. Edwards JE. In: Edwards JE. An atlas of acquired diseases of the heart and great vessels, vol. I. Philadelphia: Saunders, 1962:77-98.
67. Strauss AW, Goldring D, Kessani J, et al. Valve replacement in acute rheumatic heart disease. J Thorac Cardiovasc Surg 1974;67:659-70.
68. Lewis BS, Geft IL, Milo S, Gotsman MS. Echocardiography and valve replacement in the critically ill patient with rheumatic carditis. Ann Thorac Surg 1979;27:529-35.
69. Chauvaud S, Perier P, Toriate G, et al. Long term results of valve repair in children with acquired mitral valve incompetence. Circulation 1986;74(Suppl 1):I-104-9.
70. Marcus RH, Sareli P, Pocock WA, et al. Functional anatomy of severe mitral regurgitation in active rheumatic carditis. Am J Cardiol 1989;63:577-84.
71. Barlow JB. Aspects of active rheumatic carditis. Aust NZ J Med 1992;22:592-600.
72. Bland EF, Jones TD. Rheumatic fever and rheumatic heart disease: a twenty year report on 1000 patients followed since childhood. Circulation 1951;4:836-43.
73. Veasy LG, Tani LY, Hill HR. Persistence of acute rheumatic fever in the Intermountain area of the United States. J Pediatr 1994;124:9-16.
74. Massell BF, Chute CG, Walker AM, Kurland GS. Penicillin and the marked decrease in morbidity and mortality from rheumatic fever in the United States. N Engl J Med 1988; 318:280-6.
75. Scotti TM, Hackel DB. In: Kissani JM, ed. Anderson's pathology. St. Louis: Mosby, 1985:601.
76. Raizada V, Williams RC Jr, Chopra P, et al. Tissue distribution of lymphocytes in rheumatic heart valves as defined by monoclonal anti-T cell antibodies. Am J Med 1983;74:90-6.
77. Kemeny E, Grieve T, Marcus R, Sarelli P, Zabriskie JB. Identification of mononuclear cells and T cell subsets in rheumatic valvulitis. Clin Immunol Immunopathol 1989;52: 225-37
78. Morris K, Mohan C, Wahi RL, Anad IS, Ganguly NK. Increase in activated T cells and reduction in suppressor/ cytotoxic T cells in acute rheumatic fever and active rheumatic heart disease: a longitudinal study. J Infect Dis 1993; 167:979-83.
79. Amoils B, Morrison RC, Wadee AA, et al. Aberrant expression of HLA-DR antigen on valvular fibroblasts from patients with active rheumatic carditis. Clin Exp Immunol 1986;66: 88-94.
80. Suh EJ, Yoshinaga MM, Zabriskie JB. Antigenic specificity of valvar T-cells from rheumatic fever patients [Abstract]. Circulation 1992;86:I-362.
81. Yoshinaga M, Figueroa F, Wahid MR, Marcus RH, Suh E, Zabriskie JB. Antigenic specificity of lymphocytes isolated from valvular specimens of rheumatic fever patients. J Autoimmun 1995;8:601-13.
82. Barnett LA, Cunningham MW. A new heart cross reactive antigen in Streptococcus pyogenes is not M protein. J Infect Dis 1990;162:875-82.
83. Guilherme L, Cunha-Neto E, Coelho V, et al. Human heart-infiltrating T-cell clones from rheumatic heart disease patients recognize both streptococcal and cardiac proteins. Circulation 1995;92:415-20.